R P value
IFS 0.267 0.153
GFS 0.333 0.072
IL23 (Gn)n 0.293 0.186
IL23 (Gn)c -0.378 0.083
IL23 (Ga)n 0.16 0.513
IL23 (Ga)c 0.294 0.222
IL23 (ATn)n -0.177 0.341
IL23 (ATn)c 0.177 0.341
IL23 (ATa)c 0.509 0.133
IL23 (IT)c -0.311 0.089
IL23R (Gn)n -0.15 0.541
IL23R (Gn)c -0.122 0.62
IL23R (Ga)n 0.023 0.924
IL23R (Ga)c -0.454 0.044*
IL23R (ATn)c 0.074 0.694
IL23R (ATa)n 0.25 0.486
IL23R (ATa)c 0.102 0.779
IL23R (IT)n 0.167 0.371
IL23R (IT)c -0.107 0.567
Composite outcome: first event with doubling of SCr or declining eGFR more than 30%
IFS, interstitial fibrosis score; GFS, glomerular fibrosis score; (Gn)n, nuclear staining intensity of normal glomerulusmesangial cell; (Gn)c, cytoplasmic staining intensity of normal glomerulusmesangial cell; (Ga)n, nuclear staining intensity of atrophy glomerulusmesangial cell; (Ga)c, cytoplasmic staining intensity of atrophy glomerulusmesangial cell; (ATn)n, nuclear staining intensity of normal renal tubule; (ATn)c: cytoplasmic staining intensity of normal renal tubule; (ATa)n, nuclear staining intensity of atrophy renal tubule; (ATa)c, cytoplasmic staining intensity of atrophy renal tubule; (IT)n, nuclear staining intensity of interstitium; (IT)c,cytoplasmic staining intensity of interstitium.
*: p<0.05 indicates significance
Table 4: Spearman’s correlation association about pathological variables when reaching composite outcome.